Markers of endothelial activity are related to components of the metabolic syndrome, but not to circulating concentrations of the advanced glycation end-product Nε-carboxymethyl-lysine in healthy Swedish men

Atherosclerosis

Volumn 195, Issue 2, 2007, Pages

  Sjögren, Per ^a   Basta, Giuseppina ^b   de Caterina, Raffaele ^b   Rosell, Magdalena ^a   Basu, Samar ^c   Silveira, Angela ^a   de Faire, Ulf ^a   Vessby, Bengt ^c   Hamsten, Anders ^a   Hellenius, Mai Lis ^a   Fisher, Rachel M ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

Adhesion molecules; AGE; Cardiovascular disease; Diet; Endothelium; Metabolic syndrome

Indexed keywords

6 N CARBOXYMETHYLLYSINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; VASCULAR CELL ADHESION MOLECULE 1; VON WILLEBRAND FACTOR;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CALORIC INTAKE; CLINICAL FEATURE; CONTROLLED STUDY; DIETARY INTAKE; ENDOTHELIUM; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OXIDATIVE STRESS; PRIORITY JOURNAL; SWEDEN;

ALCOHOL DRINKING; BIOLOGICAL MARKERS; COHORT STUDIES; E-SELECTIN; ENDOTHELIUM, VASCULAR; FOOD HABITS; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; INFLAMMATION; INSULIN; INSULIN RESISTANCE; INTERCELLULAR ADHESION MOLECULE-1; LYSINE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OXIDATIVE STRESS; RISK FACTORS; SWEDEN; VASCULAR CELL ADHESION MOLECULE-1;

EID: 36049011351     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2007.06.003     Document Type: Article

References (54)

1. Furchgott R.F., and Zawadzki J.V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288 (1980) 373-376
2. Singhal A. Endothelial dysfunction: role in obesity-related disorders and the early origins of CVD. Proc Nutr Soc 64 (2005) 15-22
3. Blann A.D. Assessment of endothelial dysfunction: focus on atherothrombotic disease. Pathophysiol Haemost Thromb 33 (2003) 256-261
4. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362 (1993) 801-809
5. Kuvin J.T., and Karas R.H. Clinical utility of endothelial function testing: ready for prime time?. Circulation 107 (2003) 3243-3247
6. Blann A., and Seigneur M. Soluble markers of endothelial cell function. Clin Hemorheol Microcirc 17 (1997) 3-11
7. Schalkwijk C.G., and Stehouwer C.D. Vascular complications in diabetes mellitus: the role of endothelial dysfunction. Clin Sci (Lond) 109 (2005) 143-159
8. Quinones M.J., Nicholas S.B., and Lyon C.J. Insulin resistance and the endothelium. Curr Diab Rep 5 (2005) 246-253
9. Wilson P.W., D'Agostino R.B., Parise H., Sullivan L., and Meigs J.B. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 112 (2005) 3066-3072
10. Fox C.S., Coady S., Sorlie P.D., et al. Trends in cardiovascular complications of diabetes. JAMA 292 (2004) 2495-2499
11. Fornoni A., and Raij L. Metabolic syndrome and endothelial dysfunction. Curr Hypertens Rep 7 (2005) 88-95
12. Schram M.T., and Stehouwer C.D. Endothelial dysfunction, cellular adhesion molecules and the metabolic syndrome. Horm Metab Res 37 Suppl. 1 (2005) 49-55
13. Thorand B., Baumert J., Chambless L., et al. Elevated markers of endothelial dysfunction predict type 2 diabetes mellitus in middle-aged men and women from the general population. Arterioscler Thromb Vasc Biol 26 (2006) 398-405
14. Pasceri V., Willerson J.T., and Yeh E.T. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 102 (2000) 2165-2168
15. Kim J.A., Montagnani M., Koh K.K., and Quon M.J. Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation 113 (2006) 1888-1904
16. Vlassara H., Fuh H., Donnelly T., and Cybulsky M. Advanced glycation endproducts promote adhesion molecule (VCAM-1, ICAM-1) expression and atheroma formation in normal rabbits. Mol Med 1 (1995) 447-456
17. Bierhaus A., Chevion S., Chevion M., et al. Advanced glycation end product-induced activation of NF-kappaB is suppressed by alpha-lipoic acid in cultured endothelial cells. Diabetes 46 (1997) 1481-1490
18. Tan K.C., Chow W.S., Ai V.H., et al. Advanced glycation end products and endothelial dysfunction in type 2 diabetes. Diabetes Care 25 (2002) 1055-1059
19. Cai W., He J.C., Zhu L., et al. High levels of dietary advanced glycation end products transform low-density lipoprotein into a potent redox-sensitive mitogen-activated protein kinase stimulant in diabetic patients. Circulation 110 (2004) 285-291
20. Vlassara H., Cai W., Crandall J., et al. Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy. Proc Natl Acad Sci USA 99 (2002) 15596-15601
21. Carr A.C., and Frei B. Toward a new recommended dietary allowance for vitamin C based on antioxidant and health effects in humans. Am J Clin Nutr 69 (1999) 1086-1107
22. Lopez-Garcia E., Schulze M.B., Manson J.E., et al. Consumption of (n - 3) fatty acids is related to plasma biomarkers of inflammation and endothelial activation in women. J Nutr 134 (2004) 1806-1811
23. Setola E., Monti L.D., Galluccio E., et al. Insulin resistance and endothelial function are improved after folate and vitamin B12 therapy in patients with metabolic syndrome: relationship between homocysteine levels and hyperinsulinemia. Eur J Endocrinol 151 (2004) 483-489
24. Rosell M.S., Hellenius M.L., de Faire U.H., and Johansson G.K. Associations between diet and the metabolic syndrome vary with the validity of dietary intake data. Am J Clin Nutr 78 (2003) 84-90
25. Sjogren P., Rosell M., Skoglund-Andersson C., et al. Milk-derived fatty acids are associated with a more favorable LDL particle size distribution in healthy men. J Nutr 134 (2004) 1729-1735
26. Becker W. Food habits and nutrient intake in Sweden 1989 (1994), The Swedish National Food Administration, Uppsala, Sweden (in Swedish)
27. Silveira A.M., Yamamoto T., Adamson L., Hessel B., and Blomback B. Application of an enzyme-linked immunosorbent assay (ELISA) to von Willebrand factor (vWF) and its derivatives. Thromb Res 43 (1986) 91-102
28. Basta G., Lazzerini G., Massaro M., et al. Advanced glycation end products activate endothelium through signal-transduction receptor RAGE: a mechanism for amplification of inflammatory responses. Circulation 105 (2002) 816-822
29. Kaloudi O., Basta G., Perfetto F., et al. Circulating levels of N-epsilon-(carboxymethyl)lysine are increased in systemic sclerosis. Rheumatology 46 (2007) 412-416
30. Sjogren P., Basu S., Rosell M., et al. Measures of oxidized low-density lipoprotein and oxidative stress are not related and not elevated in otherwise healthy men with the metabolic syndrome. Arterioscler Thromb Vasc Biol 25 (2005) 2580-2586
31. Boberg M., Croon L.B., Gustafsson I.B., and Vessby B. Platelet fatty acid composition in relation to fatty acid composition in plasma and to serum lipoprotein lipids in healthy subjects with special reference to the linoleic acid pathway. Clin Sci (Lond) 68 (1985) 581-587
32. Grundy S.M., Cleeman J.I., Daniels S.R., et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement: executive summary. Circulation 112 (2005) e285-e290
33. Matthews D.R., Hosker J.P., Rudenski A.S., et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
34. Yudkin J.S., Stehouwer C.D., Emeis J.J., and Coppack S.W. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?. Arterioscler Thromb Vasc Biol 19 (1999) 972-978
35. Stam F., van Guldener C., Schalkwijk C.G., et al. Impaired renal function is associated with markers of endothelial dysfunction and increased inflammatory activity. Nephrol Dial Transplant 18 (2003) 892-898
36. Sigurdardottir V., Fagerberg B., and Hulthe J. Circulating oxidized low-density lipoprotein (LDL) is associated with risk factors of the metabolic syndrome and LDL size in clinically healthy 58-year-old men (AIR study). J Intern Med 252 (2002) 440-447
37. Krachler B., Eliasson M.C., Johansson I., Hallmans G., and Lindahl B. Trends in food intakes in Swedish adults 1986-1999: findings from the Northern Sweden MONICA (Monitoring of Trends and Determinants in Cardiovascular Disease) Study. Public Health Nutr 8 (2005) 628-635
38. Nordon. Nordic Nutrition Recommendations 2004. Copenhagen, Denmark; 2004.
39. Rosell M., Johansson G., Berglund L., et al. Associations between the intake of dairy fat and calcium and abdominal obesity. Int J Obes Relat Metab Disord 28 (2004) 1427-1434
40. Rosell M., Johansson G., Berglund L., et al. The relation between alcohol intake and physical activity and the fatty acids 14:0, 15:0 and 17:0 in serum phospholipids and adipose tissue used as markers for dairy fat intake. Br J Nutr 93 (2005) 115-121
41. Madamanchi N.R., Vendrov A., and Runge M.S. Oxidative stress and vascular disease. Arterioscler Thromb Vasc Biol 25 (2005) 29-38
42. Lusis A.J. Atherosclerosis. Nature 407 (2000) 233-241
43. Peppa M., Uribarri J., and Vlassara H. The role of advanced glycation end products in the development of atherosclerosis. Curr Diab Rep 4 (2004) 31-36
44. Dugas T.R., Morel D.W., and Harrison E.H. Dietary supplementation with beta-carotene, but not with lycopene, inhibits endothelial cell-mediated oxidation of low-density lipoprotein. Free Radic Biol Med 26 (1999) 1238-1244
45. Bau P.F., Bau C.H., Naujorks A.A., and Rosito G.A. Early and late effects of alcohol ingestion on blood pressure and endothelial function. Alcohol 37 (2005) 53-58
46. Maiorano G., Bartolomucci F., Contursi V., et al. Noninvasive detection of vascular dysfunction in alcoholic patients. Am J Hypertens 12 (1999) 137-144
47. Huntgeburth M., Ten Freyhaus H., and Rosenkranz S. Alcohol consumption and hypertension. Curr Hypertens Rep 7 (2005) 180-185
48. Dandona P., Aljada A., Chaudhuri A., Mohanty P., and Garg R. Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 111 (2005) 1448-1454
49. Stam F., Schalkwijk C.G., van Guldener C., ter Wee P.M., and Stehouwer C.D. Advanced glycation end-product peptides are associated with impaired renal function, but not with biochemical markers of endothelial dysfunction and inflammation, in non-diabetic individuals. Nephrol Dial Transplant 21 (2006) 677-682
50. Basta G., Schmidt A.M., and De Caterina R. Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes. Cardiovasc Res 63 (2004) 582-592
51. Mineo C., and Shaul P.W. HDL stimulation of endothelial nitric oxide synthase: a novel mechanism of HDL action. Trends Cardiovasc Med 13 (2003) 226-231
52. Akhand A.A., Hossain K., Mitsui H., et al. Glyoxal and methylglyoxal trigger distinct signals for map family kinases and caspase activation in human endothelial cells. Free Radic Biol Med 31 (2001) 20-30
53. O'Byrne D., Devaraj S., Islam K.N., et al. Low-density lipoprotein (LDL)-induced monocyte-endothelial cell adhesion, soluble cell adhesion molecules, and autoantibodies to oxidized-LDL in chronic renal failure patients on dialysis therapy. Metabolism 50 (2001) 207-215
54. Baidoshvili A., Krijnen P.A., Kupreishvili K., et al. N-epsilon-(carboxymethyl)lysine depositions in intramyocardial blood vessels in human and rat acute myocardial infarction: a predictor or reflection of infarction?. Arterioscler Thromb Vasc Biol 26 (2006) 2497-2503